Physician profile
Michael Christopher Yager
NPI 1255368379
$1,130.22
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $402 · 2022: $715 · 2023: $13.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $318.50 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $191.33 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $136.79 | 2022 | |
| Arbor Pharmaceuticals, INC. | $90.57 | 2021-2022 | |
| Abbvie INC. | $81.49 | 2022 | |
| Collegium Pharmaceutical, INC. | $61.61 | 2021-2022 | |
| Amgen INC. | $53.23 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $48.95 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $44.82 | 2021-2022 | |
| Grt US Holding, INC. | $42.00 | 2022 | |
| Novo Nordisk INC | $31.38 | 2022 | |
| Scilex Pharmaceuticals INC. | $15.65 | 2022 | |
| Azurity Pharmaceuticals, INC. | $13.90 | 2023 | Horizant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Yager listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.